13.07.2015 Views

media - ASD Healthcare

media - ASD Healthcare

media - ASD Healthcare

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Albumin-free 1Demonstrated bleed control 2Zero transfer step 2It’s the factor VIII with state-of-the-art purification. 1,3It comes with all-in-one reconstitution. 2When your patients turn to you, consider XYNTHA.XynThA® Antihemophilic Factor (Recombinant),Plasma/Albumin-Free is indicated for the controland prevention of bleeding episodes in patients withhemophilia A (congenital factor VIII deficiency or classichemophilia) and for surgical prophylaxis in patients withhemophilia A.XynThA does not contain von Willebrand factor and,therefore, is not indicated in von Willebrand’s disease.Important Safety Information for XYNTHA• Do not use in patients who have manifested lifethreateningim<strong>media</strong>te hypersensitivity reactions,including anaphylaxis, to the product or its components,including hamster proteins.Save on XYNTHA **Terms and conditions can be found46 InsideOut at XynThA.com.• Allergic type hypersensitivity reactions arepossible. Inform patients of the early signs orsymptoms (including hives, generalized urticaria,chest tight-ness, wheezing, and hypotension) andanaphylaxis. If these symptoms occur, advisepatients to discontinue use of the product andcontact their physician. XynThA contains traceamounts of hamster proteins. Patients may develophypersensitivity to these proteins.• Patients using coagulation factor VIII productsshould be monitored for inhibitors, which have beenreported in patients receiving XynThA.Need help accessing Pfizer medicines? Pfizer’s RSVPprogram may be able to help. Call 1-888-327-RSVP(7787) or visit www.HemophiliaVillage.com/RSVP.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!